1. Natesan and colleagues conducted a post hoc economic analysis of a trial that identified cancer patients at high risk of acute care visits during radiation therapy. 2. Additional clinician ...
In this systematic review and meta-analysis, weight loss interventions for overweight people with polycystic ovary syndrome ...
Based on a validated model of colorectal cancer screening, cell-free DNA blood tests may deliver net benefit when screening ...
In this retrospective cohort study, fecal immunochemical test completion rates in individuals aged 45 to 49 years were slightly higher than those aged 50 years, and positivity rates were slightly ...
1. 5-year progression-free survival was increased in the induction chemotherapy group compared to standard chemoradiotherapy. 2. Patients in the induction ...
Patients in the induction chemotherapy group reported more frequent grade 3 or greater adverse events. Evidence Rating Level: ...
Vyloy plus standard-of-care chemotherapy extended overall survival in patients with advanced gastric cancer. The rate of ...
The use of glucagon-like peptide 1 (GLP-1) agonists in patients with inflammatory bowel disease (IBD) was associated with few ...
No significant difference was seen regarding progression-free survival between the tivozanib-nivolumab and tivozanib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback